Approval · Notice of Compliance 18080 · 2016
VALACYCLOVIR: Notice of Compliance 18080
Issued May 6, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18080
- Date
- May 6, 2016
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALACYCLOVIR | 02454645 | Marketed |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per TAB